Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Cancer Medicine|November 2, 2024
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514Stuart L Cramer, Alyssa Terry Reddy, Charles Gene Minard, et al.
Pediatric Blood & Cancer|September 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712Katherine Tarlock, Xiaowei Liu, Charles G Minard, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
International Journal of Pediatric Endocrinology|May 15, 2015
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapyMaya Lodish, Alexandra Gkourogianni, Ethan Bornstein, et al.
Peptides|March 18, 2008
Regulation of ghrelin structure and membrane binding by phosphorylationEva Dehlin, Jianhua Liu, Samuel H Yun, et al.
Pediatric Blood & Cancer|November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyRochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Cancer Medicine|January 16, 2023
Changing incentives to ACCELERATE drug development for paediatric cancerTeresa de Rojas, Pamela Kearns, Patricia Blanc, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2023
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerationsGeorgina Meneses-Lorente, Elena Guerini, Francois Mercier, et al.
JMIR Public Health and Surveillance|May 27, 2016
An Integrated Service Delivery Model to Identify Persons Living with HIV and to Provide Linkage to HIV Treatment and Care in Prioritized Neighborhoods: A Geotargeted, Program Outcome StudyPaula M Frew, Matthew Archibald, Jay Schamel, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
Pageof 23